Only Eight Dow Components With Recent Insider Buying, JNJ is One of Them

The officers and directors of a company tend to have a unique inside view into the business, so when these insiders make purchases, investors are wise to take notice. Presumably the only reason for a company insider to choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both. Within the 30 components of the Dow Jones Industrial Average, only eight companies have experienced such buying over the trailing six month period, one of which was Johnson & Johnson (Symbol: JNJ), where an investment totaling $257.7K was made by Director John G. Morikis. Click Here to Learn Which Other Seven Dow Components Also Had Recent Insider Buying »

Morikis's average cost works out to $206.15/share. Shares of Johnson & Johnson were changing hands at $245.50 at last check, trading down about 0.7% on Wednesday. The chart below shows the one year performance of JNJ shares, versus its 200 day moving average:

Looking at the chart above, JNJ's low point in its 52 week range is $141.50 per share, with $251.71 as the 52 week high point — that compares with a last trade of $245.50.

The current annualized dividend paid by Johnson & Johnson is $5.2/share, currently paid in quarterly installments, and its most recent dividend ex-date was on 02/24/2026. Below is a long-term dividend history chart for JNJ, which can be of good help in judging whether the most recent dividend with approx. 2.1% annualized yield is likely to continue.

Click here to find out which other top insider buys by company directors you need to know about »

Also see:

• SNDR YTD Return
• CAVA Options Chain
• ETFs Holding TRST

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.